BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3346847)

  • 1. Double Hit of Hydroxichloroquine and Amiodarone Induced Renal Phospholipidosis in a Patient with Monoclonal Gammopathy and Sclerodermiform Syndrome: A Case Report and Review of the Literature.
    De la Flor JC; Rodríguez-Doyágüez P; Villa D; Zamora R; Díaz F
    Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report of progressive renal dysfunction as a consequence of amiodarone-induced phospholipidosis.
    Duineveld MD; Kers J; Vleming LJ
    Eur Heart J Case Rep; 2023 Sep; 7(9):ytad457. PubMed ID: 37743903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Livogrit prevents Amiodarone-induced toxicity in experimental model of human liver (HepG2) cells and
    Balkrishna A; Gohel V; Pathak N; Bhattacharya K; Dev R; Varshney A
    Drug Chem Toxicol; 2024 Mar; ():1-17. PubMed ID: 38425274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis.
    Lee JY; Han HJ; Lee SJ; Cho EH; Lee HB; Seok JH; Lim HS; Son WC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inkjet-printed micro-calibration standards for ultraquantitative Raman spectral cytometry.
    LaLone V; Fawaz MV; Morales-Mercado J; Mourão MA; Snyder CS; Kim SY; Lieberman AP; Tuteja A; Mehta G; Standiford TJ; Raghavendran K; Shedden K; Schwendeman A; Stringer KA; Rosania GR
    Analyst; 2019 Jun; 144(12):3790-3799. PubMed ID: 31116195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Expandable Mechanopharmaceutical Device (3): a Versatile Raman Spectral Cytometry Approach to Study the Drug Cargo Capacity of Individual Macrophages.
    LaLone V; Mourão MA; Standiford TJ; Raghavendran K; Shedden K; Stringer KA; Rosania GR
    Pharm Res; 2018 Nov; 36(1):2. PubMed ID: 30402713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal phospholipase A2.
    Shayman JA; Tesmer JJG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):932-940. PubMed ID: 30077006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology.
    Zheng N; Tsai HN; Zhang X; Rosania GR
    Mol Pharm; 2011 Oct; 8(5):1619-28. PubMed ID: 21805990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086.
    Giri SN; Hyde DM; Haynam DR; Casias M
    Mediators Inflamm; 1993; 2(4):279-85. PubMed ID: 18475534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway.
    Wilson BD; Clarkson CE; Lippmann ML
    Lung; 1993; 171(3):137-48. PubMed ID: 8505854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pulmonary inflammation in hamsters following intratracheal administration of amiodarone.
    Blake TL; Reasor MJ
    Inflammation; 1995 Feb; 19(1):55-65. PubMed ID: 7705886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes for controlled delivery of drugs to the lung.
    Taylor KM; Newton JM
    Thorax; 1992 Apr; 47(4):257-9. PubMed ID: 1585287
    [No Abstract]   [Full Text] [Related]  

  • 13. Amiodarone pulmonary toxicity.
    Retz JL; Martin WJ
    Intensive Care Med; 1992; 18(7):388-90. PubMed ID: 1469175
    [No Abstract]   [Full Text] [Related]  

  • 14. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ; Standing JE
    J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary responses to amiodarone in hamsters: comparison of intratracheal and oral administrations.
    Blake TL; Reasor MJ
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):325-31. PubMed ID: 7716773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
    Lee P; Kirk RG; Reasor MJ
    Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of amiodarone pulmonary toxicity.
    Martin WJ
    Clin Chest Med; 1990 Mar; 11(1):131-8. PubMed ID: 2182274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity.
    Reasor MJ; Kacew S
    Proc Soc Exp Biol Med; 1996 Sep; 212(4):297-304. PubMed ID: 8751986
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.